Persistence of Novel First-Line Antiretroviral Regimes in a Cohort of HIV-Positive Subjects, Coris 2008–2010Inmaculada Jarrín, Melchor Riera, Gemma Navarro et al.|Antiviral Therapy|2012Cited by 21
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir‐boosted protease inhibitor‐based versus a nonnucleoside reverse transcriptase inhibitor‐based first‐line regimenInmaculada Jarrín, Santiago Moreno, Beatriz Hernández‐Novoa et al.|HIV Medicine|2014Cited by 7